Company Filing History:
Years Active: 2025
Title: The Innovations of Anne-Cecilie Bay-Jensen
Introduction
Anne-Cecilie Bay-Jensen is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of immunology, particularly in the evaluation of diseases associated with collagen type X alpha 1. His work is essential for advancing diagnostic methods in medical science.
Latest Patents
Bay-Jensen holds a patent for the "Collagen type X alpha-1 assay." This patent provides an antibody specifically reactive with an N-terminus neo-epitope of collagen type X alpha 1 in the amino acid sequence HN-GIATKGLNGP. The assay is utilized in immunoassays for evaluating diseases such as osteoarthritis, showcasing its potential impact on healthcare.
Career Highlights
He is currently associated with Nordic Bioscience A/S, a company that focuses on innovative solutions in the field of biomedical research. His role at the company allows him to further his research and development efforts in immunology and related areas.
Collaborations
Bay-Jensen has collaborated with notable colleagues, including Yi He and Morten A Karsdal. These partnerships enhance the research capabilities and foster innovation within the field.
Conclusion
Anne-Cecilie Bay-Jensen's contributions to the field of immunology through his patent and work at Nordic Bioscience A/S highlight his importance as an inventor. His innovative approaches are paving the way for advancements in disease evaluation and treatment.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.